A set of ~800 largely isogenic deficiency stocks created by FLP-induced recombination between FRT-carrying transgenic insertions; molecularly defined deletion endpoints correspond to initial location of the progenitor insertions. Designed to fill gaps in deletion coverage and breakpoint placement; also used to replace older available deficiencies that have not been molecularly mapped.
The presence of P+PBac{XP5.WH5}BSC848 was verified using the PCR methods and primers described in FBrf0175003.
The breakpoints of Df(3R)BSC848 predicted from the Release 5 genomic coordinates of the insertion sites of the progenitor transposable elements PBac{WH}CG10420f00587 and P{XP}d06042 are 3R:21059545 ;21118634--21118719 and the cytological breakpoints predicted from these coordinates are 96C7;96D1.